- VRX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $355.1 million.
- VRX traded 12,601 shares today in the pre-market hours as of 9:29 AM.
- VRX is up 4.4% today from yesterday's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in VRX with the Ticky from Trade-Ideas. See the FREE profile for VRX NOW at Trade-Ideas More details on VRX: Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter (OTC) products, and medical devices in the areas of eye health, dermatology, and neurology therapeutic classes worldwide. Currently there are 9 analysts that rate Valeant Pharmaceuticals International a buy, no analysts rate it a sell, and 2 rate it a hold. The average volume for Valeant Pharmaceuticals International has been 2.4 million shares per day over the past 30 days. Valeant Pharmaceuticals International has a market cap of $39.0 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.96 and a short float of 5.5% with 4.55 days to cover. Shares are down 1.2% year-to-date as of the close of trading on Tuesday.